p16ink4a expression and absence of activated b-raf are independent predictors of chemosensitivity in melanoma tumors
Clicks: 186
ID: 144166
2008
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
186 views
32 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #110 of 203 articles by views in ACS chemical neuroscience
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 203 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and hampered by poor response rates to systemic chemotherapeutics. Patients who undergo isolated limb infusion (ILI) with cytotoxic drugs show high response rates and are, therefore, a good cohort for studying chemosensitivity in vivo. We used tumors from patients who underwent ILI to study the role of melanoma tumor-suppressor genes and oncogenes on melanoma chemosensitivity. Prospectively acquired tumors from 30 patients who subsequently underwent ILI with melphalan and actinomycin-D for metastatic melanoma were investigated for mRNA expression levels of p14ARF, p16INK4a, and MITFm. The mutation status of B-RAF, N-RAS, and PTEN were also determined. A high percentage of tumors had activating mutations in either B-RAF (15/30) or N-RAS (10/30) and only two tumors carried altered PTEN. High expression of p16INK4a and absence of an activating B-RAF mutation independently predicted response to treatment. Further, inducible expression of p16INK4a sensitized a melanoma cell line to death induced by melphalan or actinomycin-D. This study shows that high expression of p16INK4a or the absence of activated B-RAF correlates with in vivo response of melanoma to cytotoxic drugs.
| Reference Key |
gallagher2008neoplasia:p16ink4a
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Stuart J. Gallagher;John F. Thompson;James Indsto;Lyndee L. Scurr;Margaret Lett;Bo-Fu Gao;Ruth Dunleavey;Graham J. Mann;Richard F. Kefford;Helen Rizos |
| Journal | ACS chemical neuroscience |
| Year | 2008 |
| DOI |
10.1593/neo.08702
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.